Ayolola Eni‐Olotu

Datos Biográficos

ID7990246
NOMBREAyolola Eni‐Olotu
NOMBRESAyolola
APELLIDOEni‐Olotu
FIRMAOLOTU A E
AFILIACIONESImperial College London
ORCID0000-0002-9187-9692
VERIFICADOSí
TOTAL DE OBRAS2
TOTAL DE CITAS0
OBRAS COMO AUTOR2
OBRAS COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2021
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0

  • Achieving equitable access to health technologies during a pandemic

    Open AccessAyolola Eni‐Olotu, Rebecca Hotchkin et al.ARTICLEGlobal Public Health2025

    The COVID-19 pandemic underlined stark inequalities in timely access to health technologies worldwide. Universities, by conducting a significant amount of early biomedical research and development, have a critical but often overlooked role in determining downstream equitable access to health technologies. This paper reviews university's policies and practices regarding COVID-19 health technologies in the United Kingdom (UK) during the recent pand…

  • Who funded the research behind the Oxford–AstraZeneca Covid-19 vaccine

    Open AccessSamuel Cross, Yeanuk Rho et al.ARTICLEBMJ Global Health2021

    OBJECTIVES: The Oxford-AstraZeneca COVID-19 vaccine (ChAdOx1 nCoV-19, Vaxzevira or Covishield) builds on two decades of research and development (R&D) into chimpanzee adenovirus-vectored vaccine (ChAdOx) technology at the University of Oxford. This study aimed to approximate the funding for the R&D of ChAdOx and the Oxford-AstraZeneca vaccine and to assess the transparency of funding reporting mechanisms. METHODS: We conducted a scoping review an…